Chad M Robins sold $1.6M of Adaptive Biotechnologies (ADPT)

Executed Mar 5 2025, disclosed Mar 6 2025, 1 day later.

Value, as filed

$1.6M

219,569 sh across 3 lots

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 6 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Chad M Robins CEO and Chairman profile →

Chad M Robins (CEO and Chairman) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $14.8M of ADPT (597,271 sh across 2 lots, as filed), executed Aug 17.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 69 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Chad M Robins in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $14.8M
597,271 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 8:15 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.8M
120,595 sh across 2 lots
Exec Apr 6
Filed Apr 8 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $6.2M
470,167 sh across 2 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $8.3M
522,618 sh across 3 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $2.3M
124,998 sh × $18.44
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.9M
124,998 sh × $15.59
Exec Jan 5
Filed Jan 7 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $3.1M
160,734 sh across 2 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.3M
86,161 sh × $14.73
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET